According to the latest report by Mordor Intelligence, the biopsy devices market is estimated at USD 2.33 billion in 2026 and ...
“Urine cfRNA analysis using uRARE-seq enables sensitive detection and molecular characterization of bladder cancer, potentially enabling applications such as screening, minimal residual disease ...